Market Stimulus and Genomic Justice: Evaluating the Effects of Market Access to Human Germ-Line Enhancement
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Kennedy Institute of Ethics Journal 20 (2):161-179 (2010)
In the debates surrounding the ethical dimensions of interventions in the human genome, much attention is paid to determining whether—and if so, how—market access to these technologies ought to be managed in order to maximize social benefit. There are those who advocate a “laissez-faire” free-market approach to the development and use of genetic and genomic interventions. We are sympathetic to this view insofar as we understand the workings of the market stimulus effect. We use the term “market stimulus effect” to refer to the outcome of a set of mechanisms whereby early adoption of a new technology by wealthy consumers promotes the development of versions of this product that are cheaper to produce, or are simply ..
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Fritz Allhoff (2005). Germ-Line Genetic Enhancement and Rawlsian Primary Goods. Kennedy Institute of Ethics Journal 15 (1):39-56.
Edward B. Flowers (1998). The Ethics and Economics of Patenting the Human Genome. Journal of Business Ethics 17 (15):1737-1745.
Maxwell J. Mehlman (2005). Genetic Enhancement: Plan Now to Act Later. Kennedy Institute of Ethics Journal 15 (1):77-82.
P. H. Sedgwick (1999). The Market Economy and Christian Ethics. Cambridge University Press.
Alistair MacLeod (2000). Human Dignity, Individual Liberty, And the Free Market Ideal. Social Philosophy Today 16:113-123.
James Stacey Taylor (2006). Why the 'Black Market' Arguments Against Legalizing Organ Sales Fail. Res Publica 12 (2):163-178.
T. Phillips (2011). From the Ideal Market to the Ideal Clinic: Constructing a Normative Standard of Fairness for Human Subjects Research. Journal of Medicine and Philosophy 36 (1):79-106.
J. Robert Loftis (2005). Germ-Line Enhancement of Humans and Nonhumans. Kennedy Institute of Ethics Journal 15 (1):57-76.
John J. Hanafin (2002). Morality and the Market in China: Some Contemporary Views. Business Ethics Quarterly 12 (1):1-18.
G. K. D. Crozier Christopher Hajzler (2010). Market Stimulus and Genomic Justice: Evaluating the Effects of Market Access to Human Germ-Line Enhancement. Kennedy Institute of Ethics Journal 20 (2):pp. 161-179.
Added to index2010-08-16
Total downloads14 ( #170,159 of 1,700,300 )
Recent downloads (6 months)4 ( #161,079 of 1,700,300 )
How can I increase my downloads?